Dividend compounder review

STX

Shield Therapeutics plc · LSE · GB

Healthcare · Drug Manufacturers - Specialty & Generic

Chart Factor Intelligence Back to Screener
Score23.50/100
Confidence78.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 7.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 14.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 1.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 1.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income£-17.7M
Free Cash Flow£-3.7M
FCF Covers DividendUnknown
Debt / Equity-
P/E-
Revenue Growth 5Y108.3%
Net Margin-35.5%
ROE117.1%
Price vs Trend-27.9%
3Y Return-13.3%
5Y Return-87.4%
CurrencyGBP
Warnings

Review flags

Price currency GBP differs from financial currency USD.
No usable dividend history found.
Free cash flow is negative.
Dividend diary

Activity record

STX dividend review warning Warning · Warning

Free cash flow is negative.